Literature DB >> 29638140

Mycobacterial infection influences bone biomarker levels in patients with Crohn's disease.

Amna Naser1,1, Ahmad Qasem1,1, Saleh A Naser1,1.   

Abstract

Patients with Crohn's disease (CD) have higher risk for osteoporosis following decreased level of osteocalcin. We hypothesize that active inflammation following Mycobacterium avium subsp. paratuberculosis (MAP) infection results in elevation of undercarboxylated osteocalcin (ucOC) and downregulation of active osteocalcin in CD patients and cow-disease model (Johne's disease). In this study, we measured ucOC, active osteocalcin, and calcium levels in sera from 42 cattle (21 infected with MAP and 21 healthy cattle), 18 CD patients, and 20 controls. The level of ucOC in MAP+ bovine samples was higher than that in MAP- controls (318 ± 57.2 nmol/mL vs. 289 ± 95.8 nmol/mL, P > 0.05). Consequently, mean calcium level in bovine MAP+ was significantly higher than that in bovine-MAP- samples (9.98 ± 0.998 mg/dL vs. 7.65 ± 2.12 mg/dL, P < 0.05). Also, the level of ucOC was higher in CD-MAP+ than in CD-MAP- (561 ± 23.7 nmol/mL vs. 285 ± 19.6 nmol/mL, P < 0.05). Interestingly, the mean osteocalcin level in MAP+ bovine was lower than that in MAP- bovine (797 ± 162 pg/mL vs. 1190 ± 43 pg/mL) and it was lower in CD-MAP+ than in CD-MAP- infection (1.89 ± 0.184 ng/mL vs. 2.19 ± 0.763 ng/mL) (P < 0.05). The correlation between MAP infection and elevation of sera ucOC, reduction of active osteocalcin and increased calcium supports MAP infection role in CD and complications with osteoporosis.

Entities:  

Keywords:  Crohn’s disease; IBD; Mycobacterium avium subsp. paratuberculosis; maladie de Crohn; maladie inflammatoire de l’intestin; osteocalcin; osteoporosis; ostéocalcine; ostéocalcine décarboxylée; ostéoporose; undercarboxylated osteocalcin

Mesh:

Substances:

Year:  2018        PMID: 29638140     DOI: 10.1139/cjpp-2017-0700

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  6 in total

1.  Attenuation of Excess TNF-α Release in Crohn's Disease by Silencing of iRHOMs 1/2 and the Restoration of TGF-β Mediated Immunosuppression Through Modulation of TACE Trafficking.

Authors:  Taylor J Louis; Ahmad Qasem; Saleh A Naser
Journal:  Front Immunol       Date:  2022-05-02       Impact factor: 8.786

2.  Cathelicidin Mediates an Anti-Inflammatory Role of Active Vitamin D (Calcitriol) During M. paratuberculosis Infection.

Authors:  Joseph A Vaccaro; Ahmad Qasem; Saleh A Naser
Journal:  Front Cell Infect Microbiol       Date:  2022-04-04       Impact factor: 6.073

Review 3.  Divergent Effect of Cigarette Smoke on Innate Immunity in Inflammatory Bowel Disease: A Nicotine-Infection Interaction.

Authors:  Dania AlQasrawi; Ahmad Qasem; Saleh A Naser
Journal:  Int J Mol Sci       Date:  2020-08-13       Impact factor: 5.923

4.  Genetic polymorphisms in tumour necrosis factor receptors (TNFRSF1A/1B) illustrate differential treatment response to TNFα inhibitors in patients with Crohn's disease.

Authors:  Ahmad Qasem; Seela Ramesh; Saleh A Naser
Journal:  BMJ Open Gastroenterol       Date:  2019-02-01

Review 5.  Bone alterations in inflammatory bowel diseases.

Authors:  Dolores Sgambato; Francesca Gimigliano; Cristiana De Musis; Antimo Moretti; Giuseppe Toro; Emanuele Ferrante; Agnese Miranda; Domenico De Mauro; Lorenzo Romano; Giovanni Iolascon; Marco Romano
Journal:  World J Clin Cases       Date:  2019-08-06       Impact factor: 1.337

6.  Polymorphisms in TNF Receptor Superfamily 1B (TNFRSF1B:rs3397) are Linked to Mycobacterium avium paratuberculosis Infection and Osteoporosis in Rheumatoid Arthritis.

Authors:  Amna Naser; Ahmad K Odeh; Robert C Sharp; Ahmad Qasem; Shazia Beg; Saleh A Naser
Journal:  Microorganisms       Date:  2019-12-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.